Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07364695 · ClinicalTrials.gov registry record
Early Postoperative Function After Open Versus Ultrasound-Guided Trigger Finger Release
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 60
- Enrollment target
NCT07364695: Completed study, sponsored by Massachusetts General Hospital.
NCT07364695 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07364695 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Clinical outcomes after open trigger finger release are excellent. Minimally invasive techiques with ultrasound guidance theoretically offer advantages for faster recovery but this technique has not been compared prospectively with the standard of care (open trigger release). This study aims to prospectively analyze patient-reported outcomes in patients undergoing open vs. ultrasound-guided trigger finger release.
Primary Outcome
Study-specific survey of limitations with Activities of Daily Living. Responses for questions on the study-specific survey for limitations with ADLS utilized a Likert scale with 1 representing no difficulty with the task and 5 being unable to perform the task due to limitations from trigger finger symptoms. Likert scale responses for the 12 ADLs on the survey were summated for final scores ranging from 14 (no difficulty with any ADLs) to 70 (unable to perform any ADLs). These were standardized t
Interventions
- DEVICE UltraGuideTFR (Sonex Health, MN, USA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-06-20 |
| Est. Completion | 2024-12-31 |
What the finished NCT07364695 record still lists
NCT07364695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which UltraGuideTFR (Sonex Health, MN, USA) is the first listed.
NCT07364695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07364695 about?
NCT07364695 is a clinical study titled "Early Postoperative Function After Open Versus Ultrasound-Guided Trigger Finger Release". Clinical outcomes after open trigger finger release are excellent. Minimally invasive techiques with ultrasound guidance theoretically offer advantages for faster recovery but this technique has not been compared prospectively with the standard of care (open trigger release). This study aims to pros...
What is the current status of trial NCT07364695?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2023-06-20. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT07364695?
The interventions under investigation include: UltraGuideTFR (Sonex Health, MN, USA) (DEVICE).
Who is sponsoring clinical trial NCT07364695?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI